Bright Light Treatment At Home To Manage Chronic Pain In U.S. Veterans
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02373189|
Recruitment Status : Unknown
Verified March 2020 by Helen Burgess, Rush University Medical Center.
Recruitment status was: Active, not recruiting
First Posted : February 26, 2015
Last Update Posted : March 10, 2020
|Condition or disease||Intervention/treatment||Phase|
|Chronic Low Back Pain||Device: Bright light||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||46 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Basic Science|
|Actual Study Start Date :||August 2014|
|Actual Primary Completion Date :||September 2017|
|Estimated Study Completion Date :||December 2020|
|Experimental: Bright light||
Device: Bright light
The purpose of this R34 Pilot and Feasibility study is to develop a morning bright light treatment to help manage chronic pain and improve PTSD symptoms, mood, and sleep in US veterans. Veterans will have 7 baseline days at home, followed by a baseline pain sensitivity assessment and baseline home circadian phase assessment (dim light melatonin onset). Following an instructional home visit, patients will then self-administer morning bright light treatment for 6 days, followed by reassessments of pain sensitivity and home circadian phase. This will be repeated after a further 7 days of morning bright light treatment. The Patient Reported Outcomes Measurement Information System (PROMIS) will also be administered at every lab visit. Additionally, pain and mood (electronic diaries) and sleep (wrist actigraphy) will be assessed daily throughout baseline and treatment. Pain, mood and sleep will also be self-reported daily during a 1 month follow up after cessation of light treatment.
- Pain intensity [ Time Frame: 53 days ]How intense is the pain?
- Pain sensitivity [ Time Frame: 23 days ]Laboratory testing
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02373189
|United States, Illinois|
|Rush University Medical Center|
|Chicago, Illinois, United States, 60612|
|Principal Investigator:||Helen J Burgess, PhD||Rush University Medical Center|